Alzheimer's Disease

Showing NaN - NaN of 73

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dementia, Alzheimer's Disease Trial in San Francisco (Paired PLIE Program)

Completed
  • Dementia
  • Alzheimer's Disease
  • Paired PLIE Program
  • San Francisco, California
    UCaliforniaSF
Dec 14, 2018

Alzheimer's Disease Trial in United States (PF-04494700, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +61 more
Nov 28, 2018

Alzheimer's Disease Trial in Phoenix, San Francisco (18F-AV-1451)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +1 more
Oct 23, 2018

Alzheimer's Disease Trial in Worldwide (Idalopirdine 60 mg)

Completed
  • Alzheimer's Disease
  • Idalopirdine 60 mg
  • Birmingham, Alabama
  • +257 more
Aug 9, 2018

Alzheimer's Disease Trial in United States (Bryostatin 1, Placebo)

Completed
  • Alzheimer's Disease
  • Bryostatin 1
  • Placebo
  • Phoenix, Arizona
  • +28 more
Jun 6, 2018

Alzheimer's Disease Trial in Worldwide (LY2886721, Placebo)

Terminated
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +33 more
May 16, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 150 mg/day, TRx0237 250 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 150 mg/day
  • +2 more
  • Phoenix, Arizona
  • +120 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (TRx0237 200 mg/day, Placebo)

Completed
  • Alzheimer's Disease
  • TRx0237 200 mg/day
  • Placebo
  • Phoenix, Arizona
  • +94 more
Mar 12, 2018

Alzheimer's Disease Trial in Worldwide (SB-742457 15mg, SB-742457 35mg, Placebo)

Completed
  • Alzheimer's Disease
  • SB-742457 15mg
  • +3 more
  • Litchfield Park, Arizona
  • +101 more
Nov 3, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone XR)

Terminated
  • Alzheimer's Disease
  • Rosiglitazone XR
  • Litchfield Park, Arizona
  • +271 more
Oct 11, 2017

Alzheimer's Disease, Dementia, Alzheimer Type Trial in Worldwide (rivastigmine transdermal patch)

Completed
  • Alzheimer's Disease
  • Dementia, Alzheimer Type
  • rivastigmine transdermal patch
  • Orange, California
  • +74 more
Oct 12, 2017

Alzheimer's Disease Trial in Worldwide (Placebo, Idalopirdine)

Completed
  • Alzheimer's Disease
  • Birmingham, Alabama
  • +136 more
Aug 22, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone Extended Release 2mg, Rosiglitazone Extended Release 8mg, Placebo)

Completed
  • Alzheimer's Disease
  • Rosiglitazone Extended Release 2mg
  • +2 more
  • Sun City, Arizona
  • +193 more
Aug 3, 2017

Alzheimer's Disease Trial in Worldwide (MABT5102A, )

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +91 more
Jul 10, 2017

Alzheimer's Disease Trial in Worldwide (RO4602522, Placebo, Donepezil)

Completed
  • Alzheimer's Disease
  • Anaheim, California
  • +141 more
May 25, 2017

Alzheimer's Disease Trial in Worldwide (Rosiglitazone)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +137 more
Apr 13, 2017

Alzheimer's Disease Trial in Worldwide (Dimebon, Placebo comparator)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +100 more
Sep 24, 2016

Alzheimer's Disease, Stroke, Parkinson's Disease Trial in United States (AVP-923)

Completed
  • Alzheimer's Disease
  • +3 more
  • Phoenix, Arizona
  • +38 more
Jul 13, 2016

Alzheimer's Disease Trial in Worldwide (LY450139, Placebo)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +90 more
Jan 28, 2015

Alzheimer's Disease Trial in United States (ACC-001 (vanutide cridificar))

Completed
  • Alzheimer's Disease
  • ACC-001 (vanutide cridificar)
  • Sun City, Arizona
  • +24 more
Dec 11, 2014

Alzheimer's Disease Trial in Worldwide (ABT-126, )

Completed
  • Alzheimer's Disease
  • Fresno, California
  • +42 more
Oct 24, 2014

Alzheimer's Disease Trial in Worldwide (semagacestat)

Completed
  • Alzheimer's Disease
  • Phoenix, Arizona
  • +70 more
Sep 22, 2014

Alzheimer's Disease Neuroimaging Initiative Grand Opportunity

Completed
  • Mild Cognitive Impairment
  • Alzheimer's Disease
    • Birmingham, Alabama
    • +54 more
    Sep 15, 2014

    Alzheimer's Disease Trial in Worldwide (BMS-241027, Placebo matching BMS-241027)

    Completed
    • Alzheimer's Disease
    • Anaheim, California
    • +23 more
    Jul 23, 2014

    Alzheimer's Disease Trial in Austria, Canada, United States (Bapineuzumab)

    Terminated
    • Alzheimer's Disease
    • Birmingham, Alabama
    • +190 more
    Nov 26, 2013